Cited by 243Systemic Sclerosis and Related DiseasesNitric Oxide and Endothelin EffectsTGF-β signaling in diseases

The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.

Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1

Open access

Shi-wen, Xu, Denton, Christopher P., Holmes, Alan M., Black, Carol M., Abraham, David J., Dashwood, Michael R., Bou-Gharios, George, Pearson, Jeremy D.·2001·Journal of Investigative Dermatology

DOI 10.1046/j.1523-1747.2001.01256.x

Open this paper in CoChat — free account

Abstract

This study examines endothelin-induced modulation of extracellular matrix synthesis and remodeling by fibroblasts, and its potential role in the pathogenesis of systemic sclerosis (scleroderma). Endothelin-1 promoted fibroblast synthesis of collagen types I and III, but not fibronectin, by a mechanism dependent upon both ETA and ETB receptors. Conversely, endothelin-1 inhibited both protein expression of matrix metalloproteinase 1 and zymographic activity exclusively via ETA receptors. A dual regulatory role for endothelin-1 in transcriptional regulation was suggested by the ability of endothelin-1 to enhance steady-state levels of collagen mRNA and activate the proalpha2(I) collagen (Col1a2) promoter, but in contrast to reduce matrix metalloproteinase 1 transcript expression and suppress transcription of a human matrix metalloproteinase 1 promoter reporter construct in transient transfection assays. Although endothelin-1 significantly enhanced remodeling of three-dimensional collagen lattices populated by normal fibroblasts, this was not observed for lattices populated by systemic sclerosis fibroblasts. Promotion of matrix remodeling was dependent upon ETA receptor expression and was blocked by specific inhibitors of tyrosine kinases or protein kinase C. Reverse transcriptase polymerase chain reaction, S1 nuclease, and functional cell surface binding studies showed that normal and systemic sclerosis fibroblasts express both ETA and ETB receptors (predominantly ETA), but that ETA receptor mRNA levels and ETA binding sites on fibroblasts cultured from systemic sclerosis skin biopsies are reduced by almost 50%. Endothelin-1 is thus able to induce a fibrogenic phenotype in normal fibroblasts that is similar to that of lesional systemic sclerosis fibroblasts. Moreover, reduced responsiveness to exogenous endothelin-1 in systemic sclerosis suggests that downstream pathways may have already been activated in vivo. These data further implicate dysregulated endothelin-receptor pathways in fibroblasts in the pathogenesis of connective tissue fibrosis.

Integrity signals

Registry

Crossref · 10.1046/j.1523-1747.2001.01256.x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,925
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,645
Fibroblasts, myofibroblasts, and wound contraction
Grinnell, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.401 · Cited by 1,141
Endothelins
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711
Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro A POSSIBLE DEFECT IN THE REGULATION OR ACTIVATION OF THE SCLERODERMA FIBROBLAST
LeRoy, E. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107827 · Cited by 543
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
Hocher, B., Thöne‐Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V. R., Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H.-H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 411
Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins.
Langholz, O., Roeckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., & Eckes, B. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1903 · Cited by 397
Endothelin ET A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356
Effects of endothelins on collagen turnover in cardiac fibroblasts
Eduardo Guarda, S., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291

Show all 35 references

Sorted by citations

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 667
The endothelin system in pulmonary arterial hypertension
Galiè, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 517
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Lancaster, L., de Andrade, J. A., Stähler, G., Leconte, I., Roux, S., & Raghu, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-732oc · Cited by 500
A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression
Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.049 · Cited by 450
Pathophysiology of systemic sclerosis: current understanding and new insights
Cutolo, M., Soldano, S., & Smith, V. M. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1614915 · Cited by 369
Endothelin-1 Promotes Myofibroblast Induction through the ETA Receptor via a rac/Phosphoinositide 3-Kinase/Akt-dependent Pathway and Is Essential for the Enhanced Contractile Phenotype of Fibrotic Fibroblasts
Shiwen, X., Chen, Y., Denton, C. P., Eastwood, M., Renzoni, E. A., Bou–Gharios, G., Pearson, J. D., Dashwood, M. R., du Bois, R. M., Black, C. M., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0902 · Cited by 354
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, M. J. C., Lau, E., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G. (2014) · Circulation · doi:10.1161/circulationaha.114.006974 · Cited by 352
Cardiac fibrosis: new insights into the pathogenesis
Ma, Z., Yuan, Y., Wu, H., Zhang, X., & Tang, Q. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.28103 · Cited by 338
Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
Iglarz, M., Binkert, C., Morrison, K., Fischli, W., Gatfield, J., Treiber, A., Weller, T., Bolli, M. H., Boss, C., Buchmann, S., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142976 · Cited by 326
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Piera-Velázquez, S., Mendoza, F. A., & Jiménez, S. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040045 · Cited by 287
Pulmonary hypertension in interstitial lung disease: Fig. 1—
Behr, J., & Ryu, J. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00171307 · Cited by 269
Idiopathic Pulmonary Fibrosis
Selman, M., Thannickal, V. J., Pardo, A., Zisman, D. A., Martínez, F. J., & Lynch, J. P. (2004) · Drugs · doi:10.2165/00003495-200464040-00005 · Cited by 244
Overview of pathogenesis of systemic sclerosis
Abraham, D., Krieg, T. M., Distler, J. H. W., & Distler, O. (2006) · Rheumatology · doi:10.1093/rheumatology/ken481 · Cited by 243
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
Williams, M. H. (2005) · Heart · doi:10.1136/hrt.2005.069484 · Cited by 236
Endothelin—Biology and disease
Khimji, A.-K., & Rockey, D. C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.002 · Cited by 222
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Lagares, D., Busnadiego, Ó., García-Fernández, R. A., Kapoor, M., Liu, S., Carter, D. E., Abraham, D., Shiwen, X., Carreira, P. E., Fontaine, B. A., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33482 · Cited by 194
Mechanisms of skin fibrosis in systemic sclerosis
Jinnin, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00738.x · Cited by 180
Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK
Shiwen, X., Howat, S., Renzoni, E. A., Holmes, A. M., Pearson, J. D., Dashwood, M. R., Bou–Gharios, G., Denton, C. P., du Bois, R. M., Black, C. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311430200 · Cited by 173
How does endothelial cell injury start? The role of endothelin in systemic sclerosis
Abraham, D., & Distler, O. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2186 · Cited by 166
Endothelin is a downstream mediator of profibrotic responses to transforming growth factor β in human lung fibroblasts
Shiwen, X., Kennedy, L., Renzoni, E. A., Bou–Gharios, G., du Bois, R. M., Black, C. M., Denton, C. P., Abraham, D., & Leask, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23134 · Cited by 166
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis
Sakkas, L. I., Chikanza, I. C., & Platsoucas, C. D. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0346 · Cited by 166
Human Fibrotic Diseases: Current Challenges in Fibrosis Research
Rosenbloom, J., Macarak, E. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7113-8_1 · Cited by 160
Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B Receptors
Shiwen, X., Rodríguez‐Pascual, F., Lamas, S., Holmes, A. M., Howat, S., Pearson, J. D., Dashwood, M. R., du Bois, R. M., Denton, C. P., Black, C. M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00625-06 · Cited by 159
Endothelin-1 and Transforming Growth Factor-β1 Independently Induce Fibroblast Resistance to Apoptosis via AKT Activation
Kulasekaran, P., Scavone, C. A., Rogers, D. S., Arenberg, D. A., Thannickal, V. J., & Horowitz, J. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0447oc · Cited by 153
Enhanced Myofibroblastic Differentiation and Survival in Thy-1(−) Lung Fibroblasts
Sanders, Y. Y., Kumbla, P. A., & Hagood, J. S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0178oc · Cited by 153
The role of endothelin-1 in pulmonary arterial hypertension
Chester, A. H., & Yacoub, M. H. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.29 · Cited by 149
Fibrosis and immune dysregulation in systemic sclerosis
Chizzolini, C., Brembilla, N. C., Montanari, E., & Truchetet, M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.016 · Cited by 155
Randomized, prospective, placebo‐controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis
Seibold, J. R., Denton, C. P., Furst, D. E., Guillevin, L., Rubin, L. J., Wells, A. U., Matucci‐Cerinic, M., Riemekasten, G., Emery, P., Chadha‐Boreham, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27466 · Cited by 143
Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis
Aden, N., Nuttall, A., Shiwen, X., de Winter, P., Leask, A., Black, C. M., Denton, C. P., Abraham, D., & Stratton, R. J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.120 · Cited by 136
Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan
Clozel, M., & Salloukh, H. (2005) · Annals of Medicine · doi:10.1080/07853890410018925 · Cited by 135
Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
Leask, A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.006 · Cited by 127
Role of Endothelial to Mesenchymal Transition in the Pathogenesis of the Vascular Alterations in Systemic Sclerosis
Jiménez, S. A. (2013) · ISRN Rheumatology · doi:10.1155/2013/835948 · Cited by 130
Endothelin and endothelin receptor antagonists in systemic rheumatic disease
Mayes, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10895 · Cited by 125
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
Enevoldsen, F. C., Sahana, J., Wehland, M., Grimm, D. G., Infanger, M., & Krüger, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030824 · Cited by 130
Role of endothelin and endothelin receptor antagonists in renal disease
Neuhofer, W., & Pittrow, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01689.x · Cited by 119
IPF: new insight on pathogenesis and treatment
Harari, S. A., & Caminati, A. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02305.x · Cited by 119
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist
Cipriani, P., Benedetto, P. D., Ruscitti, P., Capece, D., Zazzeroni, F., Liakouli, V., Pantano, I., Berardicurti, O., Carubbi, F., Pecetti, G., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.150088 · Cited by 120
Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts
Shiwen, X., Renzoni, E. A., Kennedy, L., Howat, S., Chen, Y., Pearson, J. D., Bou–Gharios, G., Dashwood, M. R., du Bois, R. M., Black, C. M., et al. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.06.003 · Cited by 116
Is systemic sclerosis an antigen‐driven T cell disease?
Sakkas, L. I., & Platsoucas, C. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20315 · Cited by 120
Antibodies against Human Cytomegalovirus in the Pathogenesis of Systemic Sclerosis: A Gene Array Approach
Lunardi, C., Dolcino, M., Peterlana, D., Bason, C., Navone, R., Tamassia, N., Beri, R., Corrocher, R., & Puccetti, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030002 · Cited by 113
Role of endothelin in the cardiovascular system
Rodríguez‐Pascual, F., Busnadiego, Ó., Lagares, D., & Lamas, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.014 · Cited by 112
Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
Garsen, M., Lenoir, O., Rops, A. L. W. M. M., Dijkman, H. B. P. M., Willemsen, B. K., Kuppevelt, T. H. V., Rabelink, T. J., Berden, J. H. M., Tharaux, P., & van der Vlag, J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015091070 · Cited by 112
Anti-endothelial cell antibodies in systemic sclerosis
Mihai, C., & Tervaert, J. W. C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102400 · Cited by 107
Interstitial Lung Disease in Idiopathic Inflammatory Myopathy
Saketkoo, L. A., Ascherman, D. P., Cottin, V., Christopher‐Stine, L., Danoff, S. K., & Oddis, C. V. (2010) · Current Rheumatology Reviews · doi:10.2174/157339710791330740 · Cited by 106
Pulmonary hypertension in systemic sclerosis
Denton, C. P., & Black, C. M. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00024-3 · Cited by 97
Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
Opitz, C. F., Ewert, R., Kirch, W., & Pittrow, D. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn234 · Cited by 96
Current perspectives on the immunopathogenesis of systemic sclerosis
Fuschiotti, P. (2016) · ImmunoTargets and Therapy · doi:10.2147/itt.s82037 · Cited by 97
Ocular Manifestations of Scleroderma
Tailor, R., Gupta, A., Herrick, A. L., & Kwartz, J. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.12.007 · Cited by 90
Signalling and regulation of collagen I synthesis by ET‐1 and TGF‐β1
Horstmeyer, A., Licht, C. P. B., Scherr, G., Eckes, B., & Krieg, T. M. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05016.x · Cited by 88
Raynaud’s Phenomenon and Plasma Endothelin: Correlations with Capillaroscopic Patterns in Systemic Sclerosis
Sulli, A., Soldano, S., Pizzorni, C., Montagna, P., Secchi, M. E., Villaggio, B., SERIOLO, B., Brizzolara, R., & Cutolo, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081030 · Cited by 85
At the heart of tissue: endothelin system and end-organ damage
Iglarz, M., & Clozel, M. (2010) · Clinical Science · doi:10.1042/cs20100222 · Cited by 83
The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?
Rodríguez‐Pascual, F., Busnadiego, Ó., & González, J. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.024 · Cited by 89
Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis
Horowitz, J. C., Ajayi, I. O., Kulasekaran, P., Rogers, D. S., White, J. B. R., Townsend, S. K., White, E. S., Nho, R. S., Higgins, P., Huang, S. K., et al. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.011 · Cited by 79
The effects of endothelin‐1 on degranulation, cytokine, and growth factor production by skin‐derived mast cells
Matsushima, H., Yamada, N., Matsue, H., & Shimada, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200424912 · Cited by 78
Cellular and molecular events leading to renal tubulointerstitial fibrosis
Razzaque, M. S., & Taguchi, T. (2002) · Medical Molecular Morphology · doi:10.1007/s007950200009 · Cited by 76
Endothelin-1 upregulation mediates aging-related cardiac fibrosis
Wang, X., Guo, Z., Ding, Z., Khaidakov, M., Lin, J., Xu, Z., Sharma, S. G., Jiwani, S. S., & Mehta, J. L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.001 · Cited by 72
Pulmonary Arterial Hypertension: New Insights Into the Optimal Role of Current and Emerging Prostacyclin Therapies
Waxman, A. B., & Zamanian, R. T. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.002 · Cited by 71
Endothelin in Pulmonary Fibrosis
Fonseca, C., Abraham, D., & Renzoni, E. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0388tr · Cited by 72
Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling: Presented in part at the 72nd Scientific Session of the American Heart Association, Atlanta, GA, USA, November 7-10, 1999, and published in abstract form (Circulation 1999;100(Suppl. 1):562)
Fraccarollo, D., Galuppo, P., Bauersachs, J. K., & Ertl, G. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00256-0 · Cited by 68
Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis
Tinazzi, E., Puccetti, A., Patuzzo, G., Barbieri, A., Argentino, G., Federico, C., Dolcino, M., Beri, R., Marchi, G., Ottria, A., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/147616 · Cited by 66
A Novel Role of Endothelin-1 in Linking Toll-like Receptor 7-mediated Inflammation to Fibrosis in Congenital Heart Block
Álvarez, D., Briassouli, P., Clancy, R. M., Zavadil, J., Reed, J. H., Abellar, R. G., Halushka, M. K., Fox-Talbot, K., Barrat, F. J., & Buyon, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263657 · Cited by 66
Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy
Henry, T. W., Mendoza, F. A., & Jiménez, S. A. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102396 · Cited by 68
Systemic sclerosis: the susceptible host (genetics and environment)
Tan, F. K. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00015-2 · Cited by 64
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Cheng, Y., Wang, Y., Yin, R., Xu, Y., Zhang, L., Zhang, Y., Yang, L., & Zhao, D. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162754 · Cited by 68
Pulmonary Arterial Hypertension in Systemic Sclerosis
Ramirez, A. M., & Varga, J. (2004) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200403060-00002 · Cited by 61
Looking to the future: a new decade of pulmonary arterial hypertension therapy
McLaughlin, V. V. (2011) · European Respiratory Review · doi:10.1183/09059180.00006411 · Cited by 59
Endothelial-to-mesenchymal transition in systemic sclerosis
Benedetto, P. D., Ruscitti, P., Berardicurti, O., Vomero, M., Navarini, L., Dolo, V., Cipriani, P., & Giacomelli, R. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13599 · Cited by 60
Endothelin axis polymorphisms in patients with scleroderma
Fonseca, C., Renzoni, E. A., Sestini, P., Pantelidis, P., Lagan, A. L., Bunn, C., McHugh, N. J., Welsh, K. I., du Bois, R. M., Denton, C. P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22036 · Cited by 56
Serum galectin-3 level in systemic sclerosis
Koca, S. S., Akbas, F., Özgen, M., Yolbaş, S., İlhan, N., Gündoğdu, B., & Işık, A. T. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2346-8 · Cited by 55
Fibrosis in scleroderma
Kissin, E. Y., & Korn, J. H. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00018-8 · Cited by 53
Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
Price, L., & Howard, L. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808030-00004 · Cited by 54
Fibroblast and endothelial apoptosis in systemic sclerosis
Jun, J., Kuechle, M. K., Harlan, J. M., & Elkon, K. B. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200311000-00012 · Cited by 54
Endothelin‐1 stimulates colon cancer adjacent fibroblasts
Knowles, J. P., Shiwen, X., Haque, S., Bhalla, A., Dashwood, M. R., Yang, S., Taylor, I., Winslet, M. C., Abraham, D., & Loizidou, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26090 · Cited by 52
Tungsten carbide cobalt nanoparticles exert hypoxia-like effects on the gene expression level in human keratinocytes
Busch, W., Kühnel, D., Schirmer, K., & Scholz, S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-65 · Cited by 52
Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis
Gilbane, A. J., Derrett‐Smith, E. C., Trinder, S. L., Good, R. B., Pearce, A. C., Denton, C. P., & Holmes, A. M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1464oc · Cited by 48
The science of endothelin‐1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies
Davie, N. J., SCHERMULY, R. T., Weißmann, N., Grimminger, F., & Ghofrani, H. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02120.x · Cited by 48
Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts
Soldano, S., Montagna, P., Villaggio, B., Parodi, A., Gianotti, G., Sulli, A., SERIOLO, B., Secchi, M. E., & Cutolo, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097378 · Cited by 48
Cytokine directed therapy in scleroderma: rationale, current status, and the future
Simms, R. W., & Korn, J. H. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00015 · Cited by 48
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events
Chizzolini, C. (2006) · Annals of Medicine · doi:10.1080/07853890601098152 · Cited by 50
Vascular Changes in Bleomycin-Induced Scleroderma
Yamamoto, T., & Katayama, I. (2011) · International Journal of Rheumatology · doi:10.1155/2011/270938 · Cited by 46
Scleroderma, fibroblasts, signaling, and excessive extracellular matrix
Ihn, H. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0069-9 · Cited by 46
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
Raghu, G., King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Leconte, I., Roux, S., & Swigris, J. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00188108 · Cited by 44
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy
Thannickal, V. J., Flaherty, K. R., Martínez, F. J., & Lynch, J. P. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.8.1671 · Cited by 44
Online Monitoring of the Mechanical Behavior of Collagen Hydrogels: Influence of Corneal Fibroblasts on Elastic Modulus
Ahearne, M., Liu, K., Haj, A. J. E., Then, K. Y., Rauz, S., & Yang, Y. (2009) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2008.0650 · Cited by 44
Connective tissue associated pulmonary arterial hypertension
Coghlan, G., & Handler, C. E. (2006) · Lupus · doi:10.1191/0961203306lu2280rr · Cited by 44
Mast cells and collagen fibrillogenesis
Atiakshin, D., Buchwalow, I., & Tiemann, M. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01875-9 · Cited by 43
The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications
Rokni, M., Shaker, M. S., Kavosi, H., Shokoofi, S., Mahmoudi, M., & Farhadi, E. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02787-w · Cited by 41
Endothelin Receptor Antagonists
Clozel, M., Maresta, A., & Humbert, M. J. C. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_9 · Cited by 40
Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa
Rao, V. R., Krishnamoorthy, R. R., & Yorio, T. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.03.003 · Cited by 40
Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring
Wang, X., Liu, Y., Chun, Q., & Lu, S. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.08.007 · Cited by 40
Endothelin and endothelin receptor antagonism in portopulmonary hypertension
Neuhofer, W., Gülberg, V., & Gerbes, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01690.x · Cited by 39
Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases
Cozzi, F., Montisci, R., Marotta, H., Bobbo, F., Durigon, N., Ruscazio, M., Sfriso, P., Iliceto, S., & Todesco, S. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01684.x · Cited by 38
Molecular mechanisms of endothelial remodeling under doxorubicin treatment
Podyacheva, E., Danilchuk, M., & Toropova, Y. G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114576 · Cited by 37
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1
Akamata, K., Asano, Y., Aozasa, N., Noda, S., Taniguchi, T., Takahashi, T., Ichimura, Y., Toyama, T., & Sato, S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4529 · Cited by 37
Inhibition of Nuclear Factor-κB Activation Attenuates Tubulointerstitial Nephritis Induced by Gentamicin
Volpini, R. A., Costa, R. S., da Silva, C. G. A., & Coimbra, T. M. (2004) · Nephron Physiology · doi:10.1159/000081558 · Cited by 37
Idiopathic pulmonary fibrosis
Lynch, J. P., Fishbein, M. C., Saggar, R., Zisman, D. A., & Belperio, J. A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.3.377 · Cited by 37
The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis
Leask, A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.011 · Cited by 36
Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy
Nagasawa, H., Ueda, S., Suzuki, H., Jenkinson, C. P., Fukao, Y., Nakayama, M., Otsuka, T., Okuma, T., Clapper, W., Liu, K., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae021 · Cited by 35
Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism
Trow, T. K., & Taichman, D. B. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.02.016 · Cited by 35

Authors: Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D.
Affiliations: The Royal Free Hospital (GB)
King's College London (GB)
Corresponding author: Abraham, David J.
ORCID: Denton, Christopher P.
Holmes, Alan M.
Abraham, David J.
Dashwood, Michael R.
Pearson, Jeremy D.
Venue: Journal of Investigative Dermatology
Publisher: Elsevier BV
Published: 2001-03
Volume: 116
Issue: 3
Pages: 417-425
ISSN: 0022-202X (ISSN-L)
DOI: 10.1046/j.1523-1747.2001.01256.x
OpenAlex: W2064485592
Cited by: 243
References: 35
Citations by year: 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 6
FWCI: 5.73
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5389 d)
Locations: Journal of Investigative Dermatology (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: endothelin-1, systemic sclerosis, fibroblasts, extracellular matrix remodeling, collagen synthesis, type I collagen, type III collagen, fibronectin, MMP-1, ETA receptor, endothelin B receptor, connective tissue fibrosis, tyrosine kinase inhibitors, protein kinase C
MeSH terms: Cells, Cultured, Collagen, Connective Tissue, Extracellular Matrix, Fibroblasts, Humans, Reference Values, RNA, Messenger, Scleroderma, Systemic, Transcription, Genetic, Gene Expression, Receptors, Endothelin, Endothelin-1, Matrix Metalloproteinase 1, Receptor, Endothelin A, Receptor, Endothelin B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks